{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:32:22Z","timestamp":1697221942551},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T00:00:00Z","timestamp":1059609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1038\/sj.ejhg.5201021","type":"journal-article","created":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T11:13:38Z","timestamp":1059650018000},"page":"633-636","source":"Crossref","is-referenced-by-count":8,"title":["Possible consequences of applying guidelines to healthy women with a family history of breast cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"C J","family":"van Asperen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A E M","family":"Tollenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M M","family":"Krol-Warmerdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W E","family":"Hoogendoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M J C","family":"Seynaeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C T M","family":"Brekelmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Devilee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"Cornelisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J G M","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G H","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,7,31]]},"reference":[{"key":"BF5201021_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","volume":"71","author":"PD Pharoah","year":"1997","unstructured":"Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA : Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71: 800\u2013809.","journal-title":"Int J Cancer"},{"key":"BF5201021_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/jmg.37.8.605","volume":"37","author":"SV Hodgson","year":"2000","unstructured":"Hodgson SV, Haites NE, with BIOMED II partners: A survey of the current clinical facilities for the management of familial cancer in Europe. J Med Genet 2000; 37: 605\u2013607.","journal-title":"J Med Genet"},{"key":"BF5201021_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD : Autosomal dominant inheritance of early onset breast cancer. Cancer 1994; 73: 643\u2013651.","journal-title":"Cancer"},{"key":"BF5201021_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/fampra\/16.1.71","volume":"16","author":"GH de Bock","year":"1999","unstructured":"de Bock GH, Vliet Vlieland TP, Hageman GC, Oosterwijk JC, Springer MP, Kievit J : The assessment of genetic risk of breast cancer: a set of GP guidelines. Fam Pract 1999; 16: 71\u201377.","journal-title":"Fam Pract"},{"key":"BF5201021_CR5","first-page":"120","volume":"145","author":"CJ van Asperen","year":"2001","unstructured":"van Asperen CJ, de Bock GH, van der Horst F, de Koning HJ, Rutgers EJ : Guidelines for breast cancer surveillance for women not eligible for population screening, by individual risk assessment. Ned Tijdschr Geneeskd 2001; 145: 120\u2013125.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"BF5201021_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jmg.37.3.203","volume":"37","author":"DM Eccles","year":"2000","unstructured":"Eccles DM, Evans DG, Mackay J : Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J Med Genet 2000; 37: 203\u2013209.","journal-title":"J Med Genet"},{"key":"BF5201021_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0748-7983(98)93104-3","volume":"24","author":"RW Blamey","year":"1998","unstructured":"Blamey RW : The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group. Eur J Surg Oncol 1998; 24: 464\u2013476.","journal-title":"Eur J Surg Oncol"},{"key":"BF5201021_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jama.1995.03520310075033","volume":"273","author":"KF Hoskins","year":"1995","unstructured":"Hoskins KF, Stopfer JE, Calzone KA et al: Assessment and counseling for women with a family history of breast cancer. JAMA 1995; 273: 577\u2013585.","journal-title":"JAMA"},{"key":"BF5201021_CR9","doi-asserted-by":"crossref","unstructured":"Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 1996; 14: 1730\u20131736.","DOI":"10.1200\/JCO.1996.14.5.1730"},{"key":"BF5201021_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","volume":"277","author":"W Burke","year":"1997","unstructured":"Burke W, Daly M, Garber J, Botkin J et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997; 277: 997\u20131003.","journal-title":"JAMA"},{"key":"BF5201021_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0959-8049(00)00023-X","volume":"36","author":"PD Pharoah","year":"2000","unstructured":"Pharoah PD, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BA : Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 2000; 36: 773\u2013779.","journal-title":"Eur J Cancer"},{"key":"BF5201021_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jama.1993.03510030062035","volume":"270","author":"GA Colditz","year":"1993","unstructured":"Colditz GA, Willett WC, Hunter DJ et al: Family history, age, and risk of breast cancer, Prospective data from the Nurses' Health Study. JAMA 1993; 270: 338\u2013343.","journal-title":"JAMA"},{"key":"BF5201021_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/fampra\/18.2.135","volume":"18","author":"A Lucassen","year":"2001","unstructured":"Lucassen A, Watson E, Harcourt J, Rose P, O'Grady J : Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases. Fam Pract 2001; 18: 135\u2013140.","journal-title":"Fam Pract"},{"key":"BF5201021_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1054\/bjoc.2001.1893","volume":"85","author":"D Wonderling","year":"2001","unstructured":"Wonderling D, Hopwood P, Cull A et al: A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. Br J Cancer 2001; 85: 166\u2013170.","journal-title":"Br J Cancer"},{"key":"BF5201021_CR15","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/S0959-8049(98)00288-3","volume":"34","author":"HF Vasen","year":"1998","unstructured":"Vasen HF, Haites NE, Evans DG et al: Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer 1998; 34: 1922\u20131926.","journal-title":"Eur J Cancer"},{"key":"BF5201021_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/bcr6","volume":"1","author":"DF Easton","year":"1999","unstructured":"Easton DF : How many more breast cancer predisposition genes are there? Breast Cancer Res 1999; 1: 14\u201317.","journal-title":"Breast Cancer Res"},{"key":"BF5201021_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1200\/JCO.2001.19.4.924","volume":"19","author":"CT Brekelmans","year":"2001","unstructured":"Brekelmans CT, Seynaeve C, Bartels CCM et al: Effectiveness of breast cancer surveillance in BRCA1\/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001; 19: 924\u2013930.","journal-title":"J Clin Oncol"},{"key":"BF5201021_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL et al: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345: 159\u2013164.","journal-title":"N Engl J Med"},{"key":"BF5201021_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1148\/radiology.215.1.r00ap01267","volume":"215","author":"CK Kuhl","year":"2000","unstructured":"Kuhl CK, Schmutzler RK, Leutner CC et al: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000; 215: 267\u2013279.","journal-title":"Radiology"},{"key":"BF5201021_CR20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/jnci\/93.14.1095","volume":"93","author":"MJ Stoutjesdijk","year":"2001","unstructured":"Stoutjesdijk MJ, Boetes C, Jager GJ et al: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001; 93: 1095\u20131102.","journal-title":"J Natl Cancer Inst"},{"key":"BF5201021_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/jmg.38.10.683","volume":"38","author":"N Hallowell","year":"2001","unstructured":"Hallowell N, Jacobs I, Richards M, Mackay J, Gore M : Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy. J Med Genet 2001; 38: 683\u2013691.","journal-title":"J Med Genet"},{"key":"BF5201021_CR22","volume-title":"Comprehensive Cancer Centers","author":"O Visser","year":"2001","unstructured":"Visser O, Coebergh JWW, Schouten LJ et al: Incidence of cancer in the Netherlands. Comprehensive Cancer Centers, Utrecht, 2001."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5201021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201021","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:29:51Z","timestamp":1684373391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5201021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,31]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF5201021"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5201021","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,31]]}}}